<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3045689/" ref="ordinalpos=1002&amp;ncbi_uid=2811756&amp;link_uid=PMC3045689" image-link="/pmc/articles/PMC3045689/figure/F1/" class="imagepopup">Fig. 1.  From: Rebamipide suppresses TLR-TBK1 <span class="highlight" style="background-color:">signaling</span> <span class="highlight" style="background-color:">pathway</span> resulting in regulating IRF3/7 and IFN-?/? reduction. </a></div><br /><div class="p4l_captionBody">Inflammatory mucosa of UC patients over-expressed TBK1-IRF3/7 signaling pathway in human biopsy tissues. Real-time RT-PCR of TBK1, NAP1, IRF3, and IRF7 confirmed the relationship between mRNA expression of these genes and ulcerative colitis in 10 patients. More TBK1, NAP1, IRF3, and IRF7 mRNA was expressed in atypical, than in the normal mucosa of patients with UC.</div></div>